Works by Ossendorp, Ferry


Results: 72
    1
    2

    Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines.

    Published in:
    ChemBioChem, 2021, v. 22, n. 7, p. 1215, doi. 10.1002/cbic.202000687
    By:
    • Ende, Thomas C.;
    • Heuts, Jeroen M. M.;
    • Gential, Geoffroy P. P.;
    • Visser, Marten;
    • Graaff, Michel J.;
    • Ho, Nataschja I.;
    • Jiskoot, Wim;
    • Valentijn, A. Rob P. M.;
    • Meeuwenoord, Nico J.;
    • Overkleeft, Herman S.;
    • Codée, Jeroen D. C.;
    • Burg, Sjoerd H.;
    • Verdegaal, Els M. E.;
    • Marel, Gijsbert A.;
    • Ossendorp, Ferry;
    • Filippov, Dmitri V.
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Cationic Nanoparticle-Based Cancer Vaccines.

    Published in:
    Pharmaceutics, 2021, v. 13, n. 5, p. 596, doi. 10.3390/pharmaceutics13050596
    By:
    • Heuts, Jeroen;
    • Jiskoot, Wim;
    • Ossendorp, Ferry;
    • van der Maaden, Koen;
    • Milicic, Anita
    Publication type:
    Article
    16
    17
    18
    19

    Therapeutic cancer vaccines.

    Published in:
    Journal of Clinical Investigation, 2015, v. 125, n. 9, p. 3401, doi. 10.1172/JCI80009
    By:
    • Melief, Cornelis J. M.;
    • van Hall, Thorbald;
    • Arens, Ramon;
    • Ossendorp, Ferry;
    • van der Burg, Sjoerd H.
    Publication type:
    Article
    20

    CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitope.

    Published in:
    2008
    By:
    • Skowera, Ania;
    • Ellis, Richard J.;
    • Varela-Calviño, Ruben;
    • Arif, Sefina;
    • Guo Cai Huang;
    • Van-Krinks, Cassie;
    • Zaremba, Anna;
    • Rackham, Chloe;
    • Allen, Jennifer S.;
    • Tree, Timothy I. M.;
    • Min Zhao;
    • Dayan, Colin M.;
    • Sewell, Andrew K.;
    • Unger, Wendy;
    • Drijfhout, Jan W.;
    • Ossendorp, Ferry;
    • Roep, Bart O.;
    • Peakman, Mark;
    • Varela-Calviño, Ruben;
    • Huang, Guo Cai
    Publication type:
    journal article
    21
    22
    23
    24
    25
    26

    Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.

    Published in:
    European Journal of Immunology, 2013, v. 43, n. 10, p. 2554, doi. 10.1002/eji.201343324
    By:
    • Rosalia, Rodney A.;
    • Quakkelaar, Esther D.;
    • Redeker, Anke;
    • Khan, Selina;
    • Camps, Marcel;
    • Drijfhout, Jan W.;
    • Silva, Ana Luisa;
    • Jiskoot, Wim;
    • Hall, Thorbald;
    • Veelen, Peter A.;
    • Janssen, George;
    • Franken, Kees;
    • Cruz, Luis J.;
    • Tromp, Angelino;
    • Oostendorp, Jaap;
    • Burg, Sjoerd H.;
    • Ossendorp, Ferry;
    • Melief, Cornelis J. M.
    Publication type:
    Article
    27
    28

    Receptor-Mediated Targeting of Cathepsins in Professional Antigen Presenting Cells.

    Published in:
    Angewandte Chemie International Edition, 2009, v. 48, n. 14, p. 2442, doi. 10.1002/anie.200990068
    By:
    • Hillaert, Ulrik;
    • Verdoes, Martijn;
    • Florea, Bogdan I.;
    • Saragliadis, Anastasios;
    • Habets, Kim L. L.;
    • Kuiper, Johan;
    • Van Calenbergh, Serge;
    • Ossendorp, Ferry;
    • van der Marel, Gijsbert A.;
    • Driessen, Christoph;
    • Overkleeft, Hermen S.
    Publication type:
    Article
    29

    Receptor-Mediated Targeting of Cathepsins in Professional Antigen Presenting Cells.

    Published in:
    Angewandte Chemie International Edition, 2009, v. 48, n. 9, p. 1629, doi. 10.1002/anie.200805529
    By:
    • Hillaert, Ulrik;
    • Verdoes, Martijn;
    • Florea, Bogdan I.;
    • Saragliadis, Anastasios;
    • Habets, Kim L. L.;
    • Kuiper, Johan;
    • Van Calenbergh, Serge;
    • Ossendorp, Ferry;
    • van der Marel, Gijsbert A.;
    • Driessen, Christoph;
    • Overkleeft, Hermen S.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43

    Get into the groove! Targeting antigens to MHC class II.

    Published in:
    Immunological Reviews, 1999, v. 172, n. 1, p. 87, doi. 10.1111/j.1600-065X.1999.tb01358.x
    By:
    • van Bergen, Jeroen;
    • Ossendorp, Ferry;
    • Jordens, Reina;
    • Mommaas, A. Mieke;
    • Drijfhout, Jan-Wouter;
    • Koning, Frits
    Publication type:
    Article
    44
    45

    Cd8 T-cell recognition of human 5T4 oncofetal antigen.

    Published in:
    International Journal of Cancer, 2006, v. 119, n. 7, p. 1638, doi. 10.1002/ijc.22018
    By:
    • Smyth, Lucy JC;
    • Elkord, Eyad;
    • Taher, Taher E.I.;
    • Jiang, Hui-Rong;
    • Burt, Deborah J.;
    • Clayton, Alison;
    • van Veelen, Peter A.;
    • de Ru, Arnoud;
    • Ossendorp, Ferry;
    • Melief, Cornelis J. M.;
    • Drijfhout, Jan W.;
    • Dermime, Said;
    • Hawkins, Robert E.;
    • Stern, Peter L.
    Publication type:
    Article
    46
    47
    48
    49

    FcγR interaction is not required for effective anti‐PD‐L1 immunotherapy but can add additional benefit depending on the tumor model.

    Published in:
    International Journal of Cancer, 2019, v. 144, n. 2, p. 345, doi. 10.1002/ijc.31899
    By:
    • Sow, Heng Sheng;
    • Benonisson, Hreinn;
    • Breukel, Cor;
    • Visser, Remco;
    • Verhagen, Onno J.H.M.;
    • Bentlage, Arthur E.H.;
    • Brouwers, Conny;
    • Claassens, Jill W.C.;
    • Linssen, Margot M.;
    • Camps, Marcel;
    • van Hall, Thorbald;
    • Ossendorp, Ferry;
    • Fransen, Marieke F.;
    • Vidarsson, Gestur;
    • Verbeek, J. Sjef
    Publication type:
    Article
    50